Innovative endpoint determination system for antifungal susceptibility testing of yeasts.
about
Utility of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) and minimum effective concentration assays in the determination of antifungal susceptibility of Aspergillus fumigatus to the lipopeptide clCandida biofilms: an update.Biofilm formation by Candida dubliniensis.In vitro activity of caspofungin against Candida albicans biofilms.Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolatA quantitative real-time RT-PCR assay for mature C. albicans biofilms.Fluorometric assessment of In vitro antidermatophytic activities of antimycotics based on their keratin-penetrating power.Colorimetric assay for antifungal susceptibility testing of Aspergillus species.Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antAntifungal susceptibility testing: practical aspects and current challenges.Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.The spheroplast lysis assay for yeast in microtiter plate format.Candida albicans killing by RAW 264.7 mouse macrophage cells: effects of Candida genotype, infection ratios, and gamma interferon treatment.Sublethal injury and resuscitation of Candida albicans after amphotericin B treatment.Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assayPlant-derived decapeptide OSIP108 interferes with Candida albicans biofilm formation without affecting cell viabilityAntifungal susceptibility testing of yeasts: evaluation of technical variables for test automation.Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitroModified agar dilution susceptibility testing method for determining in vitro activities of antifungal agents, including azole compoundsA 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms.Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay.Colorimetric susceptibility testing for Aspergillus fumigatus: comparison of menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide and Alamar blue tests.Comparison of a photometric method with standardized methods of antifungal susceptibility testing of yeasts.Micafungin activity against Candida albicans with diverse azole resistance phenotypes.Development of the FUN-1 family of fluorescent probes for vacuole labeling and viability testing of yeastsComparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans.A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing.Our current understanding of fungal biofilms.Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa.Azole resistance in Candida.Binding of Candida albicans to immobilized amino acids and bovine serum albumin.Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection.Application of a tetrazolium salt with a water-soluble formazan as an indicator of viability in respiring bacteriaNew in vitro assay based on glucose consumption for determining intraconazole and amphotericin B activities against Aspergillus fumigatus.Antifungal susceptibility testingIn vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.Derivatives of the mouse cathelicidin-related antimicrobial peptide (CRAMP) inhibit fungal and bacterial biofilm formation.Influence of sub-inhibitory concentrations of conventional antifungals on metabolism of Candida albicans and on its adherence to polystyrene and extracellular matrix proteins.Nutrient-Dependent Efficacy of the Antifungal Protein YvgO Correlates to Cellular Proliferation Rate in Candida albicans 3153A and Byssochlamys fulva H25.
P2860
Q28367823-FC62C0F4-E349-4747-BC7A-59D468F06E63Q30475833-660D86A0-250E-471C-B706-5AA7229D243DQ30705127-96A7A413-3A1B-4DE5-A5B5-4E3AA6A025F4Q31114513-4C5D5E27-B45F-49E1-B3A9-680644D4FF89Q33667850-64A7FB2D-447E-48B1-9B9D-86F81F2ED897Q33891605-1077E076-4F35-4341-81AD-21C435B93944Q33965242-AFD60EBB-17DF-4A27-A3FF-3D2F400597E5Q33973504-8E07E935-F359-4C66-AC56-421A7B856FA3Q33974186-C7C20DB4-9695-414E-9564-2037EB727C0AQ33975757-7186A8ED-A93D-4565-ABAF-B4CBB8D9875AQ33982871-8EB332F3-0365-4A29-86E9-7B68BC7B7123Q33985551-6526130B-6E2F-4FB3-9C50-2FD1A5D79EB3Q34183719-7122D870-AFC0-425D-B8CA-417B6053890DQ34883266-2472FEB3-1E04-4724-A2D3-4E5E8BF38730Q35055832-EB9A90F8-722F-41EE-8BE5-AE0A606FE37CQ35067093-6241C020-6C30-4AAB-800C-EA9FA555227DQ35102365-37B1B5CE-1940-4BE3-A578-903C7205281CQ35118435-17AB0BEA-6579-4938-9F3A-ACB364A7C580Q35132244-E55C9119-D62F-4310-9E25-20F669891523Q35136757-47F85F97-B6E5-4BCC-B94E-F308924FB58CQ35260629-5D2FDBB4-6D4A-402E-9B82-3C1C99CEF481Q36519575-723864D4-2993-4119-8E2E-CFA2D7835760Q36537449-AB90D3D9-D89A-4464-AAEF-601A5239C3EDQ36547494-DC79F29B-61DC-4439-BFD9-7AE9B203ECFBQ36867925-6CA7207E-A476-47CC-A153-045DAB587453Q36869468-660B9737-5F3E-4A34-BD1B-65B08BB8E71CQ37072032-DC0F600F-D074-4448-806F-E2E0D8970EDAQ37340616-C4047A29-BD4A-480F-ABFB-1B682B02C410Q37622959-8BE97DAC-79CF-47E6-9B76-E56B5560A89FQ37734296-45A37294-7BB5-4269-8E5B-B7C99DB36FEDQ38970335-D5F2BD9A-4E60-4B79-8274-19DA47716AFDQ39569557-2C6124C8-9BDB-4125-8A4C-A1C7B975CEE8Q39789893-F972FD5C-9776-4122-98A5-835864020577Q39858623-A93956BE-4655-4B55-9107-563FEA56D254Q39867423-251763E7-AA60-4990-B73E-F75D2B6FD8D3Q40795131-BAF39263-8B17-405C-A94E-6BD2FD977C88Q40968174-51AEE6AA-F66F-4371-A393-2D39F95CE5B7Q42040325-D3E68CE1-D302-43AC-B889-AC81055C4811Q44023526-6CC20161-E2CB-4029-A495-CEDF176907E9Q53447392-7A3627C5-84F8-465D-9667-F16C6F5BCB75
P2860
Innovative endpoint determination system for antifungal susceptibility testing of yeasts.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Innovative endpoint determination system for antifungal susceptibility testing of yeasts.
@en
Innovative endpoint determination system for antifungal susceptibility testing of yeasts.
@nl
type
label
Innovative endpoint determination system for antifungal susceptibility testing of yeasts.
@en
Innovative endpoint determination system for antifungal susceptibility testing of yeasts.
@nl
prefLabel
Innovative endpoint determination system for antifungal susceptibility testing of yeasts.
@en
Innovative endpoint determination system for antifungal susceptibility testing of yeasts.
@nl
P2093
P2860
P356
P1476
Innovative endpoint determination system for antifungal susceptibility testing of yeasts.
@en
P2093
Campbell I
Grigoriew GA
P2860
P304
P356
10.1128/AAC.36.8.1619
P407
P577
1992-08-01T00:00:00Z